41results about How to "Easily terminated" patented technology

An electrical cable for shipboard use that can block water is disclosed. The electrical cable includes conductors, water swellable tapes, water swellable yarns, solid fillers, and a jacket. Each conductor is substantially wrapped with water swellable tape. The conductors are disposed adjacent to each other thereby forming interstitial voids between each of the conductors. Solid fillers and water swellable yarns are alternatively disposed in each interstitial void. Additional water swellable tape substantially envelopes the conductors, water swellable yarns, and solid fillers. The jacket is disposed on the outermost peripheral surface of the electrical cable.

A system and a method for docking a wireless communications device are provided. The system includes a docking station on which a wireless communications device is docked. A display on the docked wireless communications device provides the display for the docking system.

An apparatus having an optical structure, ridges and an electrostatic actuator with a cantilever electrode is described, wherein the ridges connect the optical structure to a supporting structure and the electrostatic drive is implemented to deflect the optical structure.

The present invention relates to micro electromechanical systems (MEMS) devices and more specifically to a process for manufacturing MEMS devices having at least one suspended structural element. The present invention seeks to provide an improved method for manufacture of MEMS devices having improved safety and increased yield and throughput compared to conventional EDP immersion process techniques. MEMS devices are made using a modified dissolution process that removes, in a selective etch step, inactive silicon to release an active silicon device from a sacrificial substrate. The present invention uses a selective etchant in conjunction with a commercial spray acid processing tool to provide a dissolution process with improved throughput, improved repeatable and uniform etch rates and reduction in the number of processing steps and chemical containment for improved safety. When the etch process is complete, the solvent spray is turned off and a spray of de-ionized water is directed onto composite structure to remove residual solvent without causing suspended elements to adhere to the support substrate.

The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead. A stimulation-induced EMG motor response is recorded with the integrated clinician programmer for each test stimulation on each electrode of the implantable lead via the at least one pair of EMG sensing electrodes so as to facilitate initial positioning of the implantable lead at a target stimulation region.

Methods and apparatus for a three-stage atrial cardioversion therapy that treats atrial arrhythmias within pain tolerance thresholds of a patient. An implantable therapy generator adapted to generate and selectively deliver a three-stage atrial cardioversion therapy and at least two leads operably each having at least one electrode adapted to be positioned proximate the atrium of the patient. The device is programmed with a set of therapy parameters for delivering a three-stage atrial cardioversion therapy to the patient via both a far-field configuration and a near-field configuration of the electrodes upon detection of an atrial arrhythmia. The three-stage atrial cardioversion therapy includes a first stage for unpinning of one or more singularities associated with an atrial arrhythmia, a second stage for anti-repinning of the one or more singularities associated with the atrial arrhythmia, both of which are delivered via the far-field configuration of the electrodes, and a third stage for extinguishing of the one or more singularities associated with the atrial arrhythmia delivered via the near-field configuration of the electrodes.

A method and composition for effecting chemical necrosis of a tissue lining of a mammalian body cavity, particularly a uterine endometrium, by delivering a caustic tissue necrosing composition, e.g., a silver nitrate and dextran paste, to the tissue to be necrosed and allowing the paste to remain in contact with the target tissue for a period of time sufficient to chemically necrose substantially the entirety of the tissue lining, and then contacting the caustic composition with a deactivating agent, e.g., an aqueous sodium chloride solution, thereby rendering the caustic composition non-caustic, and then rinsing the cavity. Compositions and methods for delivering medicaments are also disclosed.

A conductive yoke is provided insertable into a backshell adapter to provide a convenient shielding termination system for grounding braids and shields of conductors in a multiconductor cable to be connected to and grounded at a multipin electrical connector, the yoke providing ease of connection of such braids and shields to it and having direct electrical contact to the grounded surface of the connector.

Disclosed are sustained release compositions for vaginal or transdermal administration that contain a progesterone receptor modulator such as CDB-2914 (also referred to as VA-2914), and methods of using them for long term contraception or therapeutic purposes. Also disclosed are methods for making the compositions.

An infusor system for administering medications to a venous blood vessel in the body of a patient. The infusor system includes a flexible, elongated delivery tube having opposite ends. One of the ends is couplable to a supply of liquid medication, which is remote from the venous blood vessel. The system further includes a delivery component coupled to the other end of the delivery tube. This delivery component is adaptable to be placed in confronting relationship with the venous blood vessel so that medication from said supply may be introduced directly into the venous blood vessel and distributed in the body of the patient. The infusor system further includes a pressure-altering device used for increasing intraabdominal pressure in the body of the patient. Sampling of venous blood from the meningorrhachidian vasculature is also possible.

Methods and apparatus for a three-stage ventricular cardioversion and defibrillation therapy that treats ventricular tachycardia and fibrillation at low energy levels. An implantable therapy generator adapted to generate and selectively deliver a three-stage ventricular therapy and at least two leads operably each having at least one electrode adapted to be positioned proximate the ventricle of the patient. The device is programmed to deliver a three-stage therapy via both a far-field configuration and a near-field configuration of the electrodes upon detection of a ventricular arrhythmia. The three-stage therapy includes a first stage for unpinning of one or more singularities associated with the ventricular arrhythmia, a second stage for anti-repinning of the one or more singularities, both of which are delivered via the far-field configuration of the electrodes, and a third stage for extinguishing of the one or more singularities associated delivered via the near-field configuration of the electrodes.

A vehicle drive including an input coupled to an engine, an output coupled to wheels, an intermediate member between the input and output and coupled to a rotary electric machine, a friction engagement device between the input and intermediate member, and a control device. The control device, when starting the engine with the friction engagement device disengaged, engages the friction engagement device when a rotational speed difference between the input and intermediate member is equal to or less than a predetermined value; raises a rotational speed of the input using the rotary electric machine with the friction engagement device engaged to start the engine; and, when a rotational speed of the engine is equal to or more than a predetermined value, reduces an engagement pressure of the friction engagement device and the friction engagement device is returned to the engaged state when the rotational speed difference reaches a threshold.

An optical-signal vestibular-nerve stimulation device and method that provides different nerve stimulation signals to a plurality of different vestibular nerves, including at least some of the three semicircular canal nerves and the two otolith organ nerves. In some embodiments, balance conditions of the person are sensed by the implanted device, and based on the sensed balance conditions, varying infrared (IR) nerve-stimulation signals are sent to a plurality of the different vestibular nerves.

An integrated electromyography (EMG) and signal / stimulation generation clinician programmer may be coupled with an implantable temporary or permanent lead in a patient and at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. Generally, the integrated clinician programmer may comprise a portable housing, a signal / stimulation generator, and EMG signal processor, and a graphical user interface. The signal / stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The EMG signal processor may be disposed within the housing and configured to record a stimulation-induced EMG motor response for each test stimulation via the at least one EMG sensing electrode. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or a keyboard, mouse, or the like.

The present invention provides a microfluidic device comprising a body structure which comprises a fusible material. Selective application of energy (e.g. scanning radiation) produces and maintains a network of microchannels by fusing the material. There may be pons in fluid communication with one or more channels. The subject devices find use in a variety of electrophoretic applications, including clinical assays, high throughput screening for genomics, proteomics and pharmaceutical applications, point-of-care in vitro diagnostics, molecular genetic analysis and nucleic acid diagnostics, cell separations, and bioresearch generally.

A polyphase inverter employs multiple power semiconductor switches both for its operation and to distribute the current and heat loads for improved operation and cooling. The inherently high currents required for motor operation are divided among a plurality of smaller conductors and semiconductor switches, making a printed wiring board feasible both for power distribution and for control. The approach also permits shorter path lengths to the switches, reduced inductance, faster possible operation of the power switches, and reduced transient activity outside of the immediate switch area. Signals derived from various power points can enable the controller to assess actual current and power distribution and to apportion losses appropriately, or to limit total power output should the losses be deemed excessive.

An apparatus having an optical structure and ridges is described, wherein adhesive is arranged between the ridges and the optical structure, wherein the adhesive is effective to effect, after its annealing, a predetermined orientation of the optical structure in relation to a reference plane.

An infusor system for administering medications to a venous blood vessel in the body of a patient. The infusor system includes a flexible, elongated delivery tube having opposite ends. One of the ends is couplable to a supply of liquid medication, which is remote from the venous blood vessel. The system further includes a delivery component coupled to the other end of the delivery tube. This delivery component is adaptable to be placed in confronting relationship with the venous blood vessel so that medication from said supply may be introduced directly into the venous blood vessel and distributed in the body of the patient. The infusor system further includes a pressure-altering device used for increasing intraabdominal pressure in the body of the patient.

A data cable with free stripping water blocking material includes a first conductor substantially surrounded by a first foam, a second conductor longitudinally adjacent the first conductor and substantially surrounded by a second foam, a solid coat substantially surrounding the first foam of the first conductor, a filler material, a shielding member, a water swellable tape, and a jacket. The first conductor with the first foam and the solid coat and the second conductor with the second foam are substantially placed within the filler material. The shielding member is placed substantially around the filler material. The water swellable tape is placed substantially around the shielding member. The jacket is placed substantially around the water swellable tape.

Aptamers for topical delivery and methods for topical use of aptamers are described. Aptamers that bind to interleukin (IL)-23 (IL-23 aptamers) and methods of using such aptamers are also described.

Terminating a wireless connection is simplified. A printer 10 has a print unit 21 configured to print on a recording medium; a wireless communication unit 23 configured to connect wirelessly and communicate wirelessly with an external device; and a control unit 20 configured to control the print unit 21 based on print data received from the external device, and execute a communication termination process to terminate the wireless connection when a command instructing terminating the wireless connection is received from the external device.

Terminating a wireless connection is simplified. A printer has a print unit that prints on recording media; a wireless communication unit configured to communicate wirelessly; and a control unit. When print data with a specific command appended is received from the external device unit, the control unit executes a terminate communication process that cuts the wireless connection based on the specific command after controlling the print unit to print based on the print data.